What's in Develco Pharma Schweiz AG's pipeline?

Develco Pharma Schweiz AG has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Develco Pharma Schweiz AG's portfolio?

Top competitors by shared drug class: Green Cross Corporation, Middle Tennessee Research Institute, NYU Langone Health, Norwegian University of Science and Technology, Pacific Institute for Research and Evaluation.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/develco-pharma-schweiz-ag.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Develco Pharma Schweiz AG — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Develco Pharma Schweiz AG pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Naloxone HCl PR tablets	Naloxone HCl PR tablets	phase 3	Opioid antagonist	Opioid receptors (mu, delta, kappa)	Addiction Medicine / Emergency Medicine

Therapeutic area mix

Addiction Medicine / Emergency Medicine · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Green Cross Corporation · 1 shared drug class
Middle Tennessee Research Institute · 1 shared drug class
NYU Langone Health · 1 shared drug class
Norwegian University of Science and Technology · 1 shared drug class
Pacific Institute for Research and Evaluation · 1 shared drug class
Pfizer · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Develco Pharma Schweiz AG:

Cite this brief

Drug Landscape (2026). Develco Pharma Schweiz AG — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/develco-pharma-schweiz-ag. Accessed 2026-05-16.